EXEL

Exelixis (EXEL)

Exelixis Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:EXEL

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/24	05:24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EXEL	Exelixis Inc
2024/09/16	21:45	Business Wire	Exelixis Announces Final Results from Phase 3 Pivotal CABINET Study Evaluating Cabozantinib in Advanced Neuroendocrine Tumors Presented at ESMO 2024 and Published in New England Journal of Medicine	NASDAQ:EXEL	Exelixis Inc
2024/09/15	21:45	Business Wire	Exelixis Presents Final Overall Survival Results from Phase 3 CONTACT-02 Pivotal Study Evaluating Cabozantinib in Combination with an Immune Checkpoint Inhibitor in Metastatic Castration-Resistant Prostate Cancer at ESMO 2024	NASDAQ:EXEL	Exelixis Inc
2024/08/29	08:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EXEL	Exelixis Inc
2024/08/29	05:05	Business Wire	Exelixis to Webcast Fireside Chats as Part of Investor Conferences in September	NASDAQ:EXEL	Exelixis Inc
2024/08/17	08:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EXEL	Exelixis Inc
2024/08/16	09:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EXEL	Exelixis Inc
2024/08/15	08:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EXEL	Exelixis Inc
2024/08/15	06:01	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EXEL	Exelixis Inc
2024/08/13	08:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EXEL	Exelixis Inc
2024/08/10	08:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EXEL	Exelixis Inc
2024/08/10	08:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EXEL	Exelixis Inc
2024/08/10	08:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EXEL	Exelixis Inc
2024/08/10	08:31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EXEL	Exelixis Inc
2024/08/10	06:20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EXEL	Exelixis Inc
2024/08/10	06:18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EXEL	Exelixis Inc
2024/08/09	06:42	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EXEL	Exelixis Inc
2024/08/08	05:17	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EXEL	Exelixis Inc
2024/08/08	05:13	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EXEL	Exelixis Inc
2024/08/08	05:11	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EXEL	Exelixis Inc
2024/08/07	06:03	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:EXEL	Exelixis Inc
2024/08/07	05:18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EXEL	Exelixis Inc
2024/08/07	05:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EXEL	Exelixis Inc
2024/08/07	05:05	Business Wire	Exelixis Announces Second Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:EXEL	Exelixis Inc
2024/08/06	21:30	Business Wire	Exelixis Announces U.S. Food and Drug Administration (FDA) Accepted the Supplemental New Drug Application for Cabozantinib for Patients with Advanced Neuroendocrine Tumors	NASDAQ:EXEL	Exelixis Inc
2024/07/24	05:05	Business Wire	Exelixis to Release Second Quarter 2024 Financial Results on Tuesday, August 6, 2024	NASDAQ:EXEL	Exelixis Inc
2024/06/07	09:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EXEL	Exelixis Inc
2024/06/05	09:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EXEL	Exelixis Inc
2024/06/05	09:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EXEL	Exelixis Inc
2024/06/05	09:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EXEL	Exelixis Inc